User profiles for Caigang Liu

Caigang Liu

Shengjing Hospital of China Medical University
Verified email at sj-hospital.org
Cited by 3128

The expression of stem cell protein Piwil2 and piR-932 in breast cancer

H Zhang, Y Ren, H Xu, D Pang, C Duan, C Liu - Surgical oncology, 2013 - Elsevier
… Huanming Xu and Caigang Liu participated in the design of the study and Deyan Pang
performed the statistical analysis. Chao Duan conceived of the study, and participated in its …

[HTML][HTML] New perspectives for resistance to PARP inhibitors in triple-negative breast cancer

Y Han, X Yu, S Li, Y Tian, C Liu - Frontiers in Oncology, 2020 - frontiersin.org
Poly (ADP-ribose) polymerase (PARP) inhibitors are a therapeutic milestone exerting a synthetic
lethal effect in the treatment of cancer involving BRCA1/2 mutation. Theoretically, PARP …

[HTML][HTML] The sirtuin family in health and disease

…, HH Chen, XF Yu, JL Lv, YY Liu, YS Liu… - Signal transduction and …, 2022 - nature.com
Sirtuins (SIRTs) are nicotine adenine dinucleotide(+)-dependent histone deacetylases
regulating critical signaling pathways in prokaryotes and eukaryotes, and are involved in …

[HTML][HTML] Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients

…, M Luo, X Zhang, X Wei, J Gao, Z Zhao, C Liu - Oncotarget, 2014 - ncbi.nlm.nih.gov
Oct-4 and Nanog in regulating the epithelial-mesenchymal transition (EMT) and metastasis
of breast cancer has not been clarified. We found that both Oct-4 and Nanog expression …

[HTML][HTML] Nestin positively regulates the Wnt/β-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells

…, P Lu, H Zhang, H Xu, N Gao, M Li, C Liu - Breast Cancer Research, 2014 - Springer
Introduction We investigated Nestin expression in triple-negative breast cancer and examined
how the modulation of Nestin expression affects cell cycle progression, survival, invasion …

Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes

D Lin, Y Li, H Xu, J Chen, B Wang, C Liu… - American journal of …, 2013 - journals.lww.com
Objectives: The purpose of this study was to evaluate the outcome of the ratio between
metastatic and examined lymph nodes (N ratio) in gastric cancer patients with< 15 examined …

[HTML][HTML] Galectin-3 as a marker and potential therapeutic target in breast cancer

H Zhang, X Liang, C Duan, C Liu, Z Zhao - PLoS One, 2014 - journals.plos.org
Galectin-3 has a relatively high level of expression in triple-negative breast cancers and is a
potential marker for this disease. However, the clinical and prognostic implications of …

[HTML][HTML] MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway

T Liu, K Hu, Z Zhao, G Chen, X Ou, H Zhang, X Zhang… - Oncotarget, 2015 - ncbi.nlm.nih.gov
We investigated the miRNA profiles of breast cancer stem cells (CSCs) and non-CSC tumor
cells by miRNA microarray and determined the effect of altered miR-1 expression on …

Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer

…, Y Wang, G Chen, J Xue, X Zhu, Y Zhao, Y Yang, C Liu - Elife, 2022 - elifesciences.org
Background: Integrin family are known as key gears in focal adhesion for triple-negative
breast cancer (TNBC) metastasis. However, the integrin independent factor TLN1 remains …

[HTML][HTML] Targeting SOST using a small-molecule compound retards breast cancer bone metastasis

…, X Zhang, X Jiang, C Liu, X Li, Y Liu, Y Yang, C Liu - Molecular Cancer, 2022 - Springer
Background Breast cancer metastasis to the bone can be exacerbated by osteoporosis, is
associated with poor long-term survival, and has limited therapeutic options. Sclerostin (SOST…